Dr. Shum, who first joined Microsoft as a researcher in 1996, will be replaced by the company’s chief technology officer, Kevin Scott. Until his official departure, Dr. Shum will continue to serve as an advisor to CEO Satya Nadella and co-founder Bill Gates, a company spokesperson confirmed to CNBC.
“Harry has had a profound impact on Microsoft. His contributions in the fields of computer science and AI leave a legacy and a strong foundation for future innovation. I want to thank him for his leadership and partnership, and for all he has done for Microsoft,” Mr. Nadella said in a statement.
Under Dr. Shum’s guidance, Microsoft’s AI and research group has launched several healthcare-related projects in the past several years. Most recently, the company partnered with the Bar Harbor, Maine-based Jackson Laboratory to refine an AI-powered precision oncology tool, teamed up with Nuance to create the “exam room of the future” and formed an “AI Innovation Digital Alliance” with the city of Louisville, Ky., to support the local healthcare industry.
More articles on AI:
Healthcare leaders debunk 3 myths about machine learning
Baystate Health to develop AI tools that match patients to clinical trials
In 2020, AI will zero in on behavioral health, social determinants, drug resistance & more
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
